Strumento inattivo

Altre lingue Kuros Biosciences AG Swiss Exchange

Azioni

CH0325814116

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Bourse Zurich: retour dans le rouge, Roche plombe l'indice	24/04
Les ventes de Kuros s'envolent	24/04
Kuros mit erneut starkem Umsatz- und Ergebnissprung im ersten Quartal	24/04
Kuros Biosciences Posts Higher Q1 Product Sales	24/04
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales	24/04
Kuros Biosciences AG Approves Board of Director and Committee Changes	17/04
Annual General Meeting of Kuros Biosciences approves all resolutions	17/04
Bourse Zurich: le SMI poursuit sa progression, nouveau plus haut de l'année	13/03
Bourse Zurich: les indices passent l'épaule en fin de matinée	13/03
Kuros Biosciences' FY23 Attributable Loss Shrinks; Revenue Up	13/03
Kuros toujours dans le rouge en 2023 malgré des recettes plus que doublées	13/03
Kuros hat nach Umsatzsprung den Verlust verringert	13/03
Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023	13/03
Kuros Biosciences AG Reports Earnings Results for the Full Year Ended December 31, 2023	12/03
Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update	08/03
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference	01/02
Bourse Zurich: dans le rouge avant la Fed, Novartis pèse sur le SMI	31/01
US FDA Approves Kuros Biosciences' Bone Graft Granules for Interbody Use	31/01
Kuros: nouvelles autorisations pour Magnetos aux USA et en Nouvelle-Zélande	31/01
Kuros erhält weitere Zulassung für MagnetOs in den USA und Neuseeland	31/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Kuros Biosciences AG Swiss Exchange

Azioni

CH0325814116

Altre lingue

Filtri